Non-thyroid laboratory surveillance before treatment was limited, with only two patients checked for adrenal function, three for reproductive hormones, four for growth-related analytes, one for hypophysitis/abnormal prolactin, and one for diabetes. The gene discussed is PRL; the disease is diabetes mellitus.